Tidepool Showcases New Real-World Clinical Data and Landmark Women’s Health Initiative at ADA 2026 Tidepool, the nonprofit leader advancing innovation in diabetes technology, today unveiled new clinical insights and research initiatives in conjunction with the American Diabetes Association’s (ADA) 86th…
Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis Baszucki Group announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic…
Turn Therapeutics Appoints Physician-Scientist and Former FDA Commissioner, Dr. Stephen M. Hahn, as Executive Clinical and Regulatory Lead Turn Therapeutics Inc. a clinical-stage biotechnology company developing targeted, localized therapies for inflammatory skin diseases, announced the appointment of Stephen M. Hahn,…
Massive Bio and Just Worldwide Announce Strategic Partnership to Connect More Cancer Patients to Clinical Trials Massive Bio, the global leader in AI-driven clinical trial matching for cancer patients, and Just Worldwide, a leading global fieldwork and market research provider…
GE HealthCare’s next-gen SIGNA MR technology helps advance research discovery and translate innovation into clinical impact As the global magnetic resonance (MR) community convenes for the International Society for Magnetic Resonance in Medicine (ISMRM) 2026 Annual Meeting,GE HealthCare’s announced advancements…
Sunnybrook Announces $41-Million Gift to Advance Canada’s Global Leadership in Clinical Trials Sunnybrook Health Sciences Centre is proud to announce a $41M philanthropic investment in Sunnybrook Clinical Trials. The investment expands dedicated infrastructure, capacity and expertise across Sunnybrook to optimize how clinical…
Atropos Health Creates World’s Largest Body of Medical Evidence, Alexandria, for Clinical Decision Support and LLM Training to Improve Patient, Life Science, and Medical Outcomes Atropos Health, the world’s largest creator of real-world evidence (RWE) for clinical decision making, announced…
Onchilles Pharma Presents at AACR 2026 New Preclinical Data from the Systemically Delivered NEU-002 Program, Supporting Advancement Toward Development Candidate Selection Onchilles Pharma, a private biotech company advancing therapeutics targeting the ELANE pathway, announced new preclinical data from its NEU-002…
OncoNano to Present New Preclinical Data at AACR 2026 Highlighting Effective Tumor Delivery Enabled by ON-BOARD™ Platform OncoNano Medicine, Inc. a clinical-stage biotechnology company developing precision therapies using its proprietary nanotechnology platform, announced it will present new preclinical data at the…
Thermo Fisher Scientific’s PPD Clinical Research Business Collaborates with HealthVerity to Expand Real-World Data Capabilities Thermo Fisher Scientific, the world leader in serving science, today announced a strategic data collaboration with HealthVerity, a leading real-world data (RWD) marketplace, to enhance…
Clarametyx Biosciences Strengthens Executive Leadership to Accelerate Clinical Development Efforts Clarametyx Biosciences, Inc. a clinical-stage biotechnology company developing immune-enabling therapies and vaccines to address biofilm-driven chronic respiratory disease, today announced two senior leadership positions within its executive team to support…
AAD 2026: Almirall Presents New Clinical and Real‑world Evidence Across Atopic Dermatitis, Psoriasis, Actinic Keratosis and Acne Almirall S.A. a global biopharmaceutical company dedicated to medical dermatology, is presenting a broad range of clinical and real‑world data across its portfolio…